PEAR   $0.03  -37.24% Market Closed

Pear Therapeutics Inc
Total Cash 59.27M
totalCashPerShare 0.415
EBITDA -115.12M
Total Debt 37.61M
quickRatio 1.339
currentRatio 1.476
Total Revenue 12.69M
debtToEquity 122.959
Revenue/Share 0.092
ROA -0.50931
ROE -1.2475901
grossProfits 5.30M
freeCashflow -64.18M
operatingCashflow -113.89M
earningsGrowth
revenueGrowth 0.943
grossMargins 0.41752
ebitdaMargins 0.0
operatingMargins -9.381761
profitMargins 0.0
enterpriseValue -17.50M
forwardPE -0.064888895
floatShares 54.43M
sharesOutstanding 140.03M
sharesShort 3.43M
sharesShortPriorMonth 1.70M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.17%
heldPercentInstitutions 0.60%
Short Ratio help_outline 2.33%
shortPercentOfFloat 0.05%
impliedSharesOutstanding
bookValue 0.218
Price To Book help_outline 0.13
earningsQuarterlyGrowth
netIncomeToCommon -75.49M
trailingEps -0.36%
forwardEps -0.45%
enterpriseToEbitda 0.15
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.16 4Q 2022
institutionsCount 96
lastUpdated May 29, 2023, 8:47 p.m.